Biorce provides Aika, an AI-native platform designed to accelerate the clinical trials lifecycle. This solution unifies protocol design, feasibility assessment, and regulatory planning within a single workspace. The platform uses explainable AI to help clinical teams expedite trial setup, mitigate risks, and achieve faster treatment delivery.
Funding
$3.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MOVPFPAFounders
Product
Problem
The drug development process is often slowed by difficulties in clinical trial design, protocol development, and patient recruitment, leading to delays in bringing new treatments to market. Researchers face challenges in efficiently accessing and analyzing clinical data, which can increase costs and reduce the speed of drug development.
Solution
Biorce offers Jarvis, a Clinical AI Assistant designed to accelerate and streamline the clinical trial process. Jarvis leverages artificial intelligence to assist with smart study design, protocol development, feasibility analysis, and targeted patient recruitment. The platform provides rapid access to clinical data, enabling researchers to identify key studies and track meaningful information. By automating and optimizing various stages of clinical trials, Jarvis aims to reduce the time and costs associated with drug development, ultimately expediting the delivery of new therapies to patients. The AI assistant helps to reduce avoidable protocol amendments, saving costs and enhancing confidence in evaluation of the study objectives.
Target Audience
Biorce's primary customers include clinical trialists, researchers, healthcare providers, and pharmaceutical companies involved in drug development, as well as patients seeking available trials.
Features
- AI-powered clinical trial design and protocol development
- Feasibility analysis to optimize study parameters
- Targeted patient recruitment tools to accelerate enrollment
- Rapid access to and analysis of clinical data
- Identification of key studies and relevant information